Drug Adalimumab-Bwwd

Hadlima

Payments companies reported to CMS as associated with Hadlima. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$377Kassociated payments (2023-2025)
7,615clinicians with associated payments
2companies reporting

By year

2023 $91K
2024 $166K
2025 $120K

Payments reported as associated with Hadlima, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Rheumatology $97K
Gastroenterology (Internal Medicine) $61K
Physician Assistant $52K
Family $39K
Dermatology $26K
Nurse Practitioner $22K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hadlima

These are the largest totals companies reported as associated with Hadlima. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Arthur Santora New Brunswick, NJ Endocrinology, Diabetes & Metabolism $5,644.00
Jonathan Kay Worcester, MA Rheumatology $1,390.00
Steven Feldman Winston Salem, NC Dermatology $843.00
Stephen Hanauer Chicago, IL Gastroenterology (Internal Medicine) $798.00
Aline Charabaty Pishvaian Baltimore, MD Gastroenterology (Internal Medicine) $798.00
Nancy Lane Sacramento, CA $650.00
Felicia Cosman West Haverstraw, NY $603.00
Shelby Cochran Fayetteville, AR Family $492.90
Courtney Kirkland Decatur, TX Physician Assistant $457.61
Gretchen Crawford Tucson, AZ Nurse Practitioner $449.14

Prescribed Hadlima?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.